LEROZE Trademark

Trademark Overview

On Monday, June 27, 2005, a trademark application was filed for LEROZE with the United States Patent and Trademark Office. The USPTO has given the LEROZE trademark a serial number of 78658834. The federal status of this trademark filing is ABANDONED - NO STATEMENT OF USE FILED as of Monday, July 6, 2009. This trademark is owned by Glaxo Group Limited. The LEROZE trademark is filed in the Pharmaceutical Products category with the following description:

Pharmaceutical preparations and substances for the treatment of infectious diseases, pain, inflammation, sepsis, alopecia and obesity, and for the treatment of viral, metabolic, musculoskeletal, cardiovascular, cardiopulmonary, genitourinary, sexual dysfunction, oncological, respiratory, neurological, gastrointestinal, hormonal, dermatological and psychiatric related diseases and disorders and for the treatment of damaged skin and tissue; and for vaccines
leroze

General Information

Serial Number78658834
Word MarkLEROZE
Filing DateMonday, June 27, 2005
Status606 - ABANDONED - NO STATEMENT OF USE FILED
Status DateMonday, July 6, 2009
Registration Number0000000
Registration DateNOT AVAILABLE
Mark Drawing4000 - Illustration: Drawing with word(s) / letter(s) / number(s) in Block form
Published for Opposition DateTuesday, March 14, 2006

Trademark Statements

Goods and ServicesPharmaceutical preparations and substances for the treatment of infectious diseases, pain, inflammation, sepsis, alopecia and obesity, and for the treatment of viral, metabolic, musculoskeletal, cardiovascular, cardiopulmonary, genitourinary, sexual dysfunction, oncological, respiratory, neurological, gastrointestinal, hormonal, dermatological and psychiatric related diseases and disorders and for the treatment of damaged skin and tissue; and for vaccines

Classification Information

International Class005 - Pharmaceutical and veterinary preparations; sanitary preparations for medical purposes; dietetic substances adapted for medical use, food for babies; plasters, materials for dressings; material for stopping teeth, dental wax; disinfectants; preparations for destroying vermin; fungicides, herbicides.
US Class Codes006, 018, 044, 046, 051, 052
Class Status Code6 - Active
Class Status DateFriday, July 1, 2005
Primary Code005
First Use Anywhere DateNOT AVAILABLE
First Use In Commerce DateNOT AVAILABLE

Trademark Owner History

Party NameGlaxo Group Limited
Party Type20 - Owner at Publication
Legal Entity Type03 - Corporation
AddressGreenford, Middlesex UB6 ONN
GB
Party NameGlaxo Group Limited
Party Type10 - Original Applicant
Legal Entity Type03 - Corporation
AddressGreenford, Middlesex UB6 ONN
GB

Trademark Events

Event DateEvent Description
Monday, July 6, 2009ABANDONMENT NOTICE MAILED - NO USE STATEMENT FILED
Monday, July 6, 2009ABANDONMENT - NO USE STATEMENT FILED
Monday, November 17, 2008EXTENSION 5 GRANTED
Monday, November 17, 2008EXTENSION 5 FILED
Monday, November 17, 2008TEAS EXTENSION RECEIVED
Tuesday, October 28, 2008ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
Tuesday, October 28, 2008TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
Wednesday, May 7, 2008EXTENSION 4 GRANTED
Wednesday, May 7, 2008EXTENSION 4 FILED
Wednesday, May 7, 2008TEAS EXTENSION RECEIVED
Tuesday, May 6, 2008ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
Tuesday, May 6, 2008TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
Tuesday, November 6, 2007EXTENSION 3 GRANTED
Tuesday, November 6, 2007EXTENSION 3 FILED
Tuesday, November 6, 2007TEAS EXTENSION RECEIVED
Thursday, May 17, 2007EXTENSION 2 GRANTED
Thursday, May 17, 2007EXTENSION 2 FILED
Thursday, May 17, 2007TEAS EXTENSION RECEIVED
Thursday, May 10, 2007ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
Thursday, May 10, 2007TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
Monday, June 19, 2006EXTENSION 1 GRANTED
Monday, June 19, 2006EXTENSION 1 FILED
Monday, June 19, 2006TEAS EXTENSION RECEIVED
Tuesday, June 6, 2006NOA MAILED - SOU REQUIRED FROM APPLICANT
Tuesday, March 14, 2006PUBLISHED FOR OPPOSITION
Wednesday, February 22, 2006NOTICE OF PUBLICATION
Friday, January 27, 2006LAW OFFICE PUBLICATION REVIEW COMPLETED
Thursday, January 26, 2006APPROVED FOR PUB - PRINCIPAL REGISTER
Friday, January 20, 2006ASSIGNED TO EXAMINER
Friday, January 20, 2006PREVIOUS ALLOWANCE COUNT WITHDRAWN
Friday, January 20, 2006ASSIGNED TO LIE
Wednesday, January 18, 2006APPROVED FOR PUB - PRINCIPAL REGISTER
Wednesday, January 18, 2006ASSIGNED TO EXAMINER
Wednesday, January 18, 2006ASSIGNED TO EXAMINER
Friday, July 1, 2005NEW APPLICATION ENTERED IN TRAM

Related Keywords

leroze treatment diseases neurological gastrointestinal hormonal respiratory dysfunction oncological dermatological related